Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus - PubMed (original) (raw)

Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus

R G Hawley et al. J Exp Med. 1992.

Abstract

Lethally irradiated mice transplanted with bone marrow cells infected with a novel recombinant retrovirus (murine stem cell virus-interleukin 6 [MSCV-IL-6]) bearing a mouse IL-6 gene developed a fatal myeloproliferative disease within 4 wk of engraftment. The hematologic manifestations of the syndrome included elevated peripheral leukocyte counts (up to 430 x 10(3) cells/mm3) with a predominance of neutrophilic granulocytes, microcytic anemia, and thrombocytosis or thrombocytopenia. The mice showed extensive neutrophil infiltration of the lungs, liver, and occasionally lymph nodes, plus splenomegaly resulting from enhanced splenic myelopoiesis (30-60-fold increase in progenitor numbers). Despite the chronic stimulation of neutrophil excess by IL-6, bone marrow from affected mice was capable of repopulating the hematopoietic tissues (bone marrow and spleen) of lethally irradiated hosts during repeated serial transplantation. In the longest documented case, the progeny of a single MSCV-IL-6-marked cell transferred the myeloproliferative disease to two secondary, four tertiary, and two quaternary recipients (the clone endured for a total of 72 wk). These results, demonstrating considerable proliferative longevity of the IL-6-producing cells, support an in vivo role of IL-6 in the maintenance of hematopoietic precursors. Dysregulated IL-6 production also had significant systemic effects. The mice displayed increased mesangial cell proliferation in the kidney, frequent liver abnormalities, and marked alterations in plasma protein levels. Unlike previous studies where constitutive expression of exogenous IL-6 genes resulted in lymphoproliferative disorders characterized by massive plasmacytosis, minimal plasma cell expansion occurred in the MSCV-IL-6 mice during the observation period. Potential explanations for the differences in disease phenotypes observed in the present and previous studies are different cell types expressing the exogenous IL-6 genes, higher sustained circulating levels of IL-6 achieved using the MSCV-IL-6 retroviral delivery system, and/or the premature death (3-15 wk after transplantation) of the MSCV-IL-6 mice before the onset of plasmacytosis. This animal model should prove useful for further investigation of the function of IL-6 in normal and abnormal hematopoiesis and in inflammatory responses.

PubMed Disclaimer

Cited by

Harnessing transposons for cancer gene discovery.
Copeland NG, Jenkins NA. Copeland NG, et al. Nat Rev Cancer. 2010 Oct;10(10):696-706. doi: 10.1038/nrc2916. Epub 2010 Sep 16. Nat Rev Cancer. 2010. PMID: 20844553 Review.
Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression.
Lu SJ, Rowan S, Bani MR, Ben-David Y. Lu SJ, et al. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8398-402. doi: 10.1073/pnas.91.18.8398. Proc Natl Acad Sci U S A. 1994. PMID: 8078893 Free PMC article.
Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.
Yamadori T, Baba Y, Matsushita M, Hashimoto S, Kurosaki M, Kurosaki T, Kishimoto T, Tsukada S. Yamadori T, et al. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6341-6. doi: 10.1073/pnas.96.11.6341. Proc Natl Acad Sci U S A. 1999. PMID: 10339589 Free PMC article.
A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans.
Sawada A, Takihara Y, Kim JY, Matsuda-Hashii Y, Tokimasa S, Fujisaki H, Kubota K, Endo H, Onodera T, Ohta H, Ozono K, Hara J. Sawada A, et al. J Clin Invest. 2003 Dec;112(11):1707-13. doi: 10.1172/JCI18937. J Clin Invest. 2003. PMID: 14660746 Free PMC article.
PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice.
Omidvar N, Maunakea ML, Jones L, Sevcikova S, Yin B, Himmel KL, Tennant TR, Le Beau MM, Largaespada DA, Kogan SC. Omidvar N, et al. Haematologica. 2013 Mar;98(3):424-7. doi: 10.3324/haematol.2011.057067. Epub 2012 Nov 9. Haematologica. 2013. PMID: 23144197 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5953-7 - PubMed
1. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7547-51 - PubMed
1. Eur J Immunol. 1988 Jan;18(1):97-104 - PubMed
1. Cell. 1986 Jun 20;45(6):917-27 - PubMed
1. Eur J Immunol. 1988 Feb;18(2):193-7 - PubMed

Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus - PubMed (original) (raw)